Included in the National Essential Medicines List and classified as Category A of National Medical Insurance; it boasts a large market scale.

Adopts a double-layer osmotic pump controlled-release formulation and is supported by national patent technology, enabling stable blood pressure reduction, minimal side effects, and greater convenience with once-daily administration.

Produced using European and American imported equipment, featuring mature manufacturing processes, large batch production, high product quality, and sufficient production capacity.

Has passed the Consistency Evaluation of Generic Drugs, ensuring its quality and therapeutic effect are consistent with the original research drug.